Global Hospital and Nursing Home Probiotics Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hospital and Nursing Home Probiotics Sales Market Report 2024
Market Analysis and InsightsGlobal Hospital and Nursing Home Probiotics Market
Probiotics are live microorganisms intended to provide health benefits when consumed, generally by improving or restoring the gut flora.
Due to the COVID-19 pandemic, the global Hospital and Nursing Home Probiotics market size is estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Lactobacillus accounting for % of the Hospital and Nursing Home Probiotics global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Gut Health segment is altered to an % CAGR throughout this forecast period.
The United States Hospital and Nursing Home Probiotics market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Hospital and Nursing Home Probiotics include Bio - K Plus International, American Lifeline, Rising Pharmaceuticals, Becton Dickinson and Company, NutraScience Labs, Vitakem Nutraceuticals, Probium, Protexin and Nutraceutix, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Hospital and Nursing Home Probiotics Scope and Market Size
The global Hospital and Nursing Home Probiotics market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Hospital and Nursing Home Probiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Lactobacillus
Bifidobacterium
Gram-positive Cocci
Others
Gut Health
Immunity
Wellness
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Bio - K Plus International
American Lifeline
Rising Pharmaceuticals
Becton Dickinson and Company
NutraScience Labs
Vitakem Nutraceuticals
Probium
Protexin
Nutraceutix
Nebraska Cultures
Mercola
Eva Nutra
UP4 Probiotics
Probiotics are live microorganisms intended to provide health benefits when consumed, generally by improving or restoring the gut flora.
Due to the COVID-19 pandemic, the global Hospital and Nursing Home Probiotics market size is estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Lactobacillus accounting for % of the Hospital and Nursing Home Probiotics global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Gut Health segment is altered to an % CAGR throughout this forecast period.
The United States Hospital and Nursing Home Probiotics market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Hospital and Nursing Home Probiotics include Bio - K Plus International, American Lifeline, Rising Pharmaceuticals, Becton Dickinson and Company, NutraScience Labs, Vitakem Nutraceuticals, Probium, Protexin and Nutraceutix, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Hospital and Nursing Home Probiotics Scope and Market Size
The global Hospital and Nursing Home Probiotics market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Hospital and Nursing Home Probiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Lactobacillus
Bifidobacterium
Gram-positive Cocci
Others
Segment by Application
Gut Health
Immunity
Wellness
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Bio - K Plus International
American Lifeline
Rising Pharmaceuticals
Becton Dickinson and Company
NutraScience Labs
Vitakem Nutraceuticals
Probium
Protexin
Nutraceutix
Nebraska Cultures
Mercola
Eva Nutra
UP4 Probiotics
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices